Literature DB >> 23205572

MicroRNA-200b is overexpressed in endometrial adenocarcinomas and enhances MMP2 activity by downregulating TIMP2 in human endometrial cancer cell line HEC-1A cells.

Yinmei Dai1, Wei Xia, Tao Song, Xueting Su, Jie Li, Shaohua Li, Ying Chen, Wei Wang, Hongmei Ding, Xuemei Liu, Hui Li, Qiang Zhao, Ningsheng Shao.   

Abstract

MicroRNAs (miRNAs) play important roles in tumorigenesis and metastasis. In this study, we investigated miR-200b expression in endometrial adenocarcinomas and normal adjacent tissues and found that miR-200b is more highly expressed in cancer tissues than in normal adjacent tissues. A novel target of miR-200b, tissue inhibitor of metalloproteinase 2 (TIMP2), was predicted using a bioinformatics approach and was confirmed in human endometrial cancer cell line HEC-1A cells by luciferase assay, quantitative real-time polymerase chain reaction, western blotting, and enzyme-linked immunosorbent assay. We found that miR-200b repressed TIMP2 expression at both the messenger RNA and protein levels, although a family member, miR-200a, had no such effect. Using reverse gelatin zymography, we showed that miR-200b enhances matrix metallopeptidase 2 (MMP2) activity by downregulating TIMP2 expression in HEC-1A cells. These data suggest that miR-200b may play an important role in the metastasis of endometrial adenocarcinomas.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23205572      PMCID: PMC3569964          DOI: 10.1089/nat.2012.0385

Source DB:  PubMed          Journal:  Nucleic Acid Ther        ISSN: 2159-3337            Impact factor:   5.486


  32 in total

1.  A novel method to monitor the expression of microRNAs.

Authors:  Han-Jiang Fu; Jie Zhu; Ming Yang; Zhuo-Yuan Zhang; Yi Tie; Hong Jiang; Zhi-Xian Sun; Xiao-Fei Zheng
Journal:  Mol Biotechnol       Date:  2006-03       Impact factor: 2.695

2.  MicroRNA expression profiles in serous ovarian carcinoma.

Authors:  Eun Ji Nam; Heejei Yoon; Sang Wun Kim; Hoguen Kim; Young Tae Kim; Jae Hoon Kim; Jae Wook Kim; Sunghoon Kim
Journal:  Clin Cancer Res       Date:  2008-05-01       Impact factor: 12.531

3.  Metalloproteinase-2, -7 and -9 and tissue inhibitor of metalloproteinase-1 and -2 expression in normal, hyperplastic and neoplastic endometrium: a clinical-pathological correlation study.

Authors:  O Graesslin; A Cortez; R Fauvet; M Lorenzato; P Birembaut; E Daraï
Journal:  Ann Oncol       Date:  2006-01-11       Impact factor: 32.976

4.  The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2.

Authors:  Sun-Mi Park; Arti B Gaur; Ernst Lengyel; Marcus E Peter
Journal:  Genes Dev       Date:  2008-04-01       Impact factor: 11.361

5.  Menstrual activity of matrix metalloproteinases is decreased in endometrium regenerating after thermal ablation.

Authors:  J L Brun; C Galant; D Delvaux; P Lemoine; P Henriet; P J Courtoy; E Marbaix
Journal:  Hum Reprod       Date:  2008-12-01       Impact factor: 6.918

6.  [Expression of microRNAs in endometrioid adenocarcinoma].

Authors:  Xia Liu; Wei Xia; Yin-mei Dai; Ning-sheng Shao; Wei-yuan Zhang
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2009-05-19

7.  MicroRNAs and their target messenger RNAs associated with endometrial carcinogenesis.

Authors:  Todd Boren; Yin Xiong; Ardeshir Hakam; Robert Wenham; Sachin Apte; ZhengZheng Wei; Siddharth Kamath; Dung-Tsa Chen; Holly Dressman; Johnathan M Lancaster
Journal:  Gynecol Oncol       Date:  2008-05-21       Impact factor: 5.482

8.  MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations.

Authors:  Yannick Ladeiro; Gabrielle Couchy; Charles Balabaud; Paulette Bioulac-Sage; Laura Pelletier; Sandra Rebouissou; Jessica Zucman-Rossi
Journal:  Hepatology       Date:  2008-06       Impact factor: 17.425

9.  The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1.

Authors:  Philip A Gregory; Andrew G Bert; Emily L Paterson; Simon C Barry; Anna Tsykin; Gelareh Farshid; Mathew A Vadas; Yeesim Khew-Goodall; Gregory J Goodall
Journal:  Nat Cell Biol       Date:  2008-03-30       Impact factor: 28.824

10.  Down-regulation of miR-141 in gastric cancer and its involvement in cell growth.

Authors:  Ying Du; Yanjun Xu; Ling Ding; Haomi Yao; Hong Yu; Tianhua Zhou; Jianmin Si
Journal:  J Gastroenterol       Date:  2009-04-11       Impact factor: 7.527

View more
  14 in total

1.  Post-transcriptional regulation of MMP2 mRNA by its interaction with miR-20a and Nucleolin in breast cancer cell lines.

Authors:  Sayantani Das; Soumasree De; Sumita Sengupta
Journal:  Mol Biol Rep       Date:  2021-03-31       Impact factor: 2.316

2.  MiR-301a promotes cell proliferation by directly targeting TIMP2 in multiple myeloma.

Authors:  Bo Liang; Jun-Jie Yin; Xin-Rong Zhan
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

3.  Post-transcriptional Regulation of MMP16 and TIMP2 Expression via miR-382, miR-410 and miR-200b in Endometrial Cancer.

Authors:  Beata Rak; Dawid Mehlich; Filip Garbicz; Zofia Domosud; Wiktor Paskal; Janina M Marczewska; Paweł K Włodarski
Journal:  Cancer Genomics Proteomics       Date:  2017 Sep-Oct       Impact factor: 4.069

4.  miR-200 promotes the mesenchymal to epithelial transition by suppressing multiple members of the Zeb2 and Snail1 transcriptional repressor complexes.

Authors:  R Perdigão-Henriques; F Petrocca; G Altschuler; M P Thomas; M T N Le; S M Tan; W Hide; J Lieberman
Journal:  Oncogene       Date:  2015-03-23       Impact factor: 9.867

5.  HOXA-AS2 promotes type I endometrial carcinoma via miRNA-302c-3p-mediated regulation of ZFX.

Authors:  Ning Song; Ying Zhang; Fanfei Kong; Hui Yang; Xiaoxin Ma
Journal:  Cancer Cell Int       Date:  2020-07-31       Impact factor: 5.722

Review 6.  Impact of Nutrition on Non-Coding RNA Epigenetics in Breast and Gynecological Cancer.

Authors:  Rosanna H E Krakowsky; Trygve O Tollefsbol
Journal:  Front Nutr       Date:  2015-05-27

7.  MicroRNA-365 targets multiple oncogenes to inhibit proliferation, invasion, and self-renewal of aggressive endometrial cancer cells.

Authors:  Chunfang Wang; Ke Su; Yanyan Zhang; Weiwei Zhang; Danxia Chu; Qian Zhao; Ruixia Guo
Journal:  Cancer Manag Res       Date:  2018-10-30       Impact factor: 3.989

Review 8.  MicroRNAS in endometrial cancer: recent advances and potential clinical applications.

Authors:  Megumi Yanokura; Kouji Banno; Miho Iida; Haruko Irie; Kiyoko Umene; Kenta Masuda; Yusuke Kobayashi; Eiichiro Tominaga; Daisuke Aoki
Journal:  EXCLI J       Date:  2015-02-02       Impact factor: 4.068

9.  Comparative DNA methylome analysis of endometrial carcinoma reveals complex and distinct deregulation of cancer promoters and enhancers.

Authors:  Bo Zhang; XiaoYun Xing; Jing Li; Rebecca F Lowdon; Yan Zhou; Nan Lin; Baoxue Zhang; Vasavi Sundaram; Katherine B Chiappinelli; Ian S Hagemann; David G Mutch; Paul J Goodfellow; Ting Wang
Journal:  BMC Genomics       Date:  2014-10-06       Impact factor: 3.969

10.  The clock gene PER1 suppresses expression of tumor-related genes in human oral squamous cell carcinoma.

Authors:  Han-Xue Li; Xiao-Juan Fu; Kai Yang; Dan Chen; Hong Tang; Qin Zhao
Journal:  Oncotarget       Date:  2016-04-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.